Buprenorphine is combined with naloxone in the opioid use disorder (OUD) medication called Suboxone. Buprenorphine is a partial opioid agonist that relieves opioid withdrawal symptoms and cravings. Naloxone, an opioid antagonist, is added to buprenorphine to deter misuse of this medication. Naloxone acts as a misuse-deterrent because it will trigger precipitated withdrawal symptoms if someone injects or snorts Suboxone.
What Does Naloxone Do in Suboxone?
Quick Answer
Naloxone is a vital component of Suboxone, an OUD medication. It prevents people from misusing their medication by sending them into opioid withdrawal if they crush and snort their medication or inject it. The addition of naloxone to buprenorphine encourages medication compliance so that people can maintain their recovery.
What Is Buprenorphine & How Is It Used?
Buprenorphine is a partial opioid agonist that is used as a medication for addiction treatment (MAT) for opioid use disorder (OUD).[1] It is administered as a tablet, sublingual or buccal film, implant, or injection.
As a partial opioid agonist, buprenorphine does not produce the same euphoric high that full opioid agonists like fentanyl, heroin and oxycodone do. However, it provides enough opioid activity that it prevents opioid cravings and eliminates withdrawal symptoms. In this way, it serves as a treatment for OUD.
That said, some people may attempt to misuse buprenorphine because of its opioid effects. That’s where naloxone comes in.
Why Is Naloxone Combined With Buprenorphine?
Naloxone is combined with buprenorphine in Suboxone as an additional misuse-deterrent.
When Suboxone is dissolved under the tongue, the naloxone component is not readily absorbed because it has a low bioavailability and sublingual absorption rate compared to buprenorphine.[2] Therefore, when Suboxone is taken sublingually as directed, naloxone is not absorbed and the patient only experiences the therapeutic effects of the buprenorphine.
However, naloxone becomes active if Suboxone is injected or snorted. If a patient tries to misuse Suboxone, the naloxone will be absorbed along with the buprenorphine, binding preferentially to the body’s opioid receptors and preventing the patient from getting high off Suboxone. [2]
Misusing Naloxone/Buprenorphine Results in Precipitated Withdrawal
If someone snorts or injects Suboxone, they will go into immediate precipitated withdrawal, which includes distressing symptoms, such as: [8]
- Sweating
- Muscle and bone pain
- Insomnia
- Runny nose and teary eyes
- Agitation and anxiety
- Diarrhea, nausea and stomach cramps
Knowing that misusing Suboxone won’t result in euphoria and will cause precipitated withdrawal can prevent misuse of the medication and also prevent a Suboxone overdose.
Naloxone vs. Suboxone
Naloxone is an opioid antagonist that, on its own, is a medication that can rapidly reverse the life-threatening effects of an opioid overdose.
When it’s combined with buprenorphine, it’s an “inactive” ingredient and only becomes active if the medication is misused. It prevents people from misusing their OUD medication and helps maintain recovery.
Suboxone, on the other hand, is the brand name for the combination medication consisting of buprenorphine and naloxone. Suboxone is prescribed to treat opioid use disorder, whereas naloxone, on its own, is not.
Are Buprenorphine and Naloxone Safe?
Yes, combination medications with both buprenorphine and naloxone are safe and effective for treating opioid use disorder (OUD).
Naloxone does not absorb at the same rate as buprenorphine, with less than 10% bioavailability through sublingual absorption. Therefore, if taken appropriately, the only medication that is absorbed by the body is buprenorphine. Moreover, naloxone is a very safe medication and has very few side effects. Rates of allergy to this medication are exceedingly low.
Combination medications also contain more buprenorphine than naloxone, generally at a ratio of 4 to 1.[3] These are examples of medications containing buprenorphine and naloxone for the treatment of OUD:[4]
- Suboxone: 2 mg buprenorphine/0.5 mg naloxone; 4 mg buprenorphine/1 mg naloxone; 8 mg buprenorphine/2 mg naloxone; 12 mg buprenorphine/3 mg naloxone
- Zubsolv: 0.7 mg buprenorphine/0.18 mg naloxone; 1.4 mg buprenorphine/0.6 mg naloxone; 2.9 mg buprenorphine/0.71 mg naloxone; 5.7 mg buprenorphine/1.4 mg naloxone; 8.6 mg buprenorphine/2.1 mg naloxone; 11.4 mg buprenorphine/2.9 mg naloxone
- Bunavail: 2.1 mg buprenorphine/0.3 mg naloxone; 4.2 mg buprenorphine/0.7 mg naloxone; 6.3 mg buprenorphine/1 mg naloxone
- Cassipa: 16 mg buprenorphine/4 mg naloxone
Effectiveness of Buprenorphine and Naloxone in OUD Treatment
Suboxone is remarkably effective in treating OUD.
In one study of people recovering from heroin use disorder, nearly 90% of people using Suboxone were still abstinent after 8 months. [5]
In another study, 82% of people who used both methadone and Suboxone preferred Suboxone.[6]
Since this medication can be taken at home (rather than in a doctor’s office or another clinical setting), it’s much more convenient, which could keep people engaged in treatment longer.[7]
If you are recovering from an opioid use disorder and think Suboxone might be helpful, talk to your doctor or reach out to us here at Bicycle Health for more information.
Reviewed By Peter Manza, PhD
Peter Manza, PhD received his BA in Psychology and Biology from the University of Rochester and his PhD in Integrative Neuroscience at Stony Brook University. He is currently working as a research scientist in Washington, DC. His research focuses on the role ... Read More
- Buprenorphine. Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/medication-assisted-treatment/medications-counseling-related-conditions/buprenorphine. May 2021. Accessed January 2022.
- Reconsidering the Usefulness of Adding Naloxone to Buprenorphine. Frontiers in Psychology. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517938/. September 2020. Accessed January 2022.
- Suboxone: Rationale, Science, Misconceptions. The Ochsner Journal. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855417/. Spring 2018. Accessed January 2022.
- Buprenorphine/Naloxone (Suboxone). National Alliance on Mental Illness. https://www.nami.org/About-Mental-Illness/Treatments/Mental-Health-Medications/Types-of-Medication/Buprenorphine/Buprenorphine-Naloxone-(Suboxone). Accessed January 2022.
- Medically Assisted Recovery From Opiate Dependence Within the Context of the UK Drug Strategy (Buprenorphine-Naloxone) Patients Compared. Journal of Substance Abuse Treatment. https://www.sciencedirect.com/science/article/abs/pii/S0740547212000803. January 2013. Accessed August 2022.
- Suboxone Efficacy in Treating Drug Addiction: Comparison with Methadone and Monitoring of Patients in Therapy at SERT of Masala. IRIS UniPA. https://iris.unipa.it/handle/10447/244120. 2017. Accessed August 2022.
- Long-Term Suboxone Treatment and Its Benefit on Long-Term Remission for Opiate Dependence. Journal of Psychiatry. https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.682.3650&rep=rep1&type=pdf. 2014. Accessed August 2022.
- Dunn KE, Bird HE, Bergeria CL, Ware OD, Strain EC, Huhn AS. Operational definition of precipitated opioid withdrawal. Front Psychiatry. 2023;14:1141980. Published 2023 Apr 20. doi:10.3389/fpsyt.2023.1141980
Download Our Free Program Guide
Learn about our program, its effectiveness and what to expect
Imagine what’s possible on the other side of opioid use disorder.
Our science-backed approach boasts 95% of patients reporting no withdrawal symptoms at 7 days. We can help you achieve easier days and a happier future.